Darling, RG, Catlett, CL, Huebner, KD, Jarrett, DG. Threats in bioterrorism. I: CDC category A agents. Emerg Med Clin North Am. 2002;20:273–309.CrossRefGoogle ScholarPubMed

Department of Homeland Security. National Incident Management System. FEMA Publication P-501, December 2008:1–156.Google Scholar

National Incident Management System (NIMS). NIMS Implementation Activities for Hospitals and Healthcare Systems. Available at: www.fema.gov/pdf/emergency/nims/imp_act_hos_hlth.pdf. Accessed November22, 2015.Google Scholar

NIMS Implementation for Healthcare Organizations Guidance January 2015. Available at: www.phe.gov/Preparedness/planning/hpp/reports/Documents/nims-implementation-guide-jan2015.pdf. Accessed November 22, 2015.Google Scholar

McLaughlin, S. Ready for anything. Health Facilities Management. 2007; 20: 39–40, 42.Google Scholar

Hospital Incident Command System Guidebook 2014. California Emergency Medical Services Authority (EMSA), 2014. Available at: www.emsa.ca.gov/media/default/HICS/HICS_Guidebook_2014_11.pdf. Accessed November 22, 2015Google Scholar

Centers for Disease Control and Prevention (CDC). Revised US surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases – United States and worldwide, December 2003. MMWR Morb Mortal Wkly Rep. 2003;52: 1202–1206.Google Scholar

Nam, WW. Role of SARS screening clinic in the ED. Can J Emerg Med. 2004;6:78–79.CrossRefGoogle ScholarPubMed

McGeer, AJ. Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do? Clin Infect Dis. 2009;48 (Suppl 1):S14–S19.Google Scholar

World Health Organization (WHO). Current WHO phase of pandemic alert for Pandemic (H1N1) 2009. Available at: www.who.int/csr/disease/swineflu/phase/en/. Accessed November 22, 2015.Google Scholar

Centers for Disease Control and Prevention. Enhanced Ebola Screening to Start at Five U.S. Airports and New Tracking Program for all People Entering U.S. from Ebola-affected Countries. Available at: www.cdc.gov/media/releases/192014/p1008-ebola-screening.html.Google Scholar

Toner, E, Waldhorn, R. What hospitals should do to prepare for an influenza pandemic. Biosecur Bioterror. 2006;4(4): 397–402.CrossRefGoogle ScholarPubMed

Esbitt, D. The Strategic National Stockpile: roles and responsibilities of health care professionals for receiving the stockpile assets. Disaster Manag Response. 2003;1:68–70Google Scholar

Hota, S, McGeer, A. Antivirals and the control of influenza outbreaks. Clin Infect Dis. 2007;45:1362–1368.CrossRefGoogle ScholarPubMed

Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS), Supplement I: Infection Control in Healthcare, Home, and Community Settings, CDC. Available at: www.cdc.gov/ncidod/sars/guidance/I/healthcare.htm. Accessed August 26, 2009.Google Scholar

Department of Health and Human Services (HHS). Interim Guidance on Planning for the Use of Surgical Masks and Respirators in Health Care Settings during an Influenza Pandemic. Available at: www.pandemicflu.gov/plan/healthcare/maskguidan-cehc.html. Accessed August 26, 2009.Google Scholar

Chevalier, MS, Chung, W, Smith, J, et al. Ebola virus disease cluster in the United States–Dallas County, Texas, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(46):1087–1088.Google ScholarPubMed

MacIntyre, CR, Chughtai, AA, Seale, H, et al. Uncertainty, risk analysis and change for Ebola personal protective equipment guidelines. Int J Nurs Stud. 2015;52(5):899–903.Google Scholar

Department of Health and Human Services (HHS). HHS Pandemic Influenza Plan. Available at: www.hhs.gov/pandemicflu/plan/. Accessed August 26, 2009.Google Scholar

Bartlett, JG, Borio, L. The current status of planning for pandemic influenza and implications for health care planning in the United States. Clin Infect Dis. 2008; 46:919–25.Google Scholar

Cinti, SK, Wilkerson, W, Holmes, JG, et al. Pandemic influenza and acute care centers: taking care of sick patients in a nonhospital setting. Biosecur Bioterror. 2008;6:335–348.CrossRefGoogle Scholar

Barnitz, L, Berkwits, M. The health care response to pandemic influenza. Ann Intern Med. 2006;145:135–137.Google ScholarPubMed

Inglesby, TV, O’Toole, T, Henderson, DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236–2252.CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2010; 59(RR-6):1–36.Google Scholar

Henderson, DA, Inglesby, TV, Bartlett, JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999;281: 2127–2137.CrossRefGoogle Scholar

Inglesby, TV, Dennis, DT, Henderson, DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000;283(17): 2281–2290.Google Scholar

Dennis, DT, Inglesby, TV, Henderson, DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285:2763–2773.Google Scholar

Arnon, SS, Schechter, R, Inglesby, TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059–1070.Google Scholar

Borio, L, Inglesby, T, Peters, CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 2002;287:2391–2405.CrossRefGoogle ScholarPubMed

Christian, MD, Poutanen, SM, Loutfy, MR, et al. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420.Google Scholar

Cheng, VCC, Lau, SKP, Woo, PCY, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20:660–694.CrossRefGoogle ScholarPubMed

Hui, DS, Chan, MC, Wu, AK, Ng, PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J. 2004;80:373–381.CrossRefGoogle ScholarPubMed

Arabi, YM, Arifi, AA, Balkhy, HH, et al. Clinical course and outcomes of critically ill patients with Middle East Respiratory Syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389.Google Scholar

Schieffelin, JS, Shaffer, JG, Goba, A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371(22):2092.Google Scholar

Hien, ND, Ha, NH, Van, NT, et al. Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004–2005. Emerg Infect Dis. 2009; 15(1):19–23.CrossRefGoogle ScholarPubMed

Sampathkumar, P. West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc. 2003; 78:1137–1143.Google Scholar

Lewis, MD, Pavlin, JA, Mansfield, JL, et al. Disease outbreak detection system using syndromic data in the greater Washington DC area. Am J Prev Med. 2002;23:180–186.Google Scholar

Sejvar, JJ, Chowdary, Y, Schomogyi, M, et al. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis. 2004;190:1833–1840.Google Scholar

State-specific mortality from stroke and distribution of place of death: United States, 1999. MMWR Morb Mortal Wkly Rep. 2002;51: 429–433.Google Scholar

Schlech, WF III, Ward, JI, Band, JD. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985;253: 1749–1754.CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention. Recognition of illness associated with the intentional release of a biologic agent. MMWR Morb Mortal Wkly Rep. 2001;50(41):893–897.Google Scholar

Buehler, JW, Berkelman, RL, Hartley, DM, Peters, CJ. Syndromic surveillance and bioterrorism-related epidemics. Emerg Infect Dis. 2003;9:1197–1204.Google Scholar

Roush, S, Birkhead, G, Koo, D, Cobb, A, Fleming, D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA. 1999; 282(2):164–170.Google Scholar

Buehler, JW, Berkelman, RL, Hartley, DM, et al. Syndromic surveillance and bioterrorism related epidemics. Emerg Infect Dis. 2003;9:1197–1204.CrossRefGoogle ScholarPubMed

Borchardt, SM, Ritger, KA, Dworkin, MS. Categorization, prioritization, and surveillance of potential bioterrorism agents. Infect Dis Clin North Am. 2006;20:213–225.Google Scholar

Sokolow, LZ, Grady, N, Rolka, H, et al. Deciphering data anomalies in BioSense. MMWR Morb Mortal Wkly Rep. 2005;54(Suppl):133–139.Google Scholar

Rotz, LD, Hughes, JM. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease. Nat Med. 2004;10:S130–S136.Google Scholar

Blank, S, Moskin, LC, Zucker, JR. An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001. Emerg Infect Dis. 2003;9:615–622.Google Scholar

Dewan, PK, Fry, AM, Laserson, K, et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis. 2002;8: 1066–1072.Google Scholar

Christopher, GW, Cieslak, TJ, Pavlin, JA, et al. Biological warfare: a historical perspective. JAMA. 1997;278:412–417.CrossRefGoogle ScholarPubMed

Sugishima, M. Aum Shinrikyo and the Japanese law on bioterrorism. Prehosp Disaster Med. 2003;18:179–183.Google Scholar

Office of Technology Assessment, US Congress. Proliferation of Weapons of Mass Destruction. Washington, DC: US Government Printing Office; 1993. Publication OTA-ISC–559.Google Scholar

Centers for Disease Control and Prevention. Smallpox Response Plan and Guidelines, Version 3.0. 2002. Available at: www.bt.cdc.gov/agent/smallpox/response-plan/. Accessed November 22, 2015.Google Scholar

Centers for Disease Control and Prevention.Smallpox Case Definitions. Available at: www.bt.cdc.gov/agent/smallpox/diagnosis/casedefinition.asp. Accessed November 22, 2015.Google Scholar

Centers for Disease Control and Prevention. CDC Interim Guidance for Revaccination of Eligible Persons Who Participated in the US Civilian Smallpox Preparedness and Response Program, October 2008. Available at: www.bt.cdc.gov/agent/smallpox/revaxmemo.asp. Accessed November 22, 2015.Google Scholar

Pasetti, MF, Cuberos, L, Horn, TL, et al. An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes. Vaccine. 2008;26:1773–1785.Google Scholar

Centers for Disease Control and Prevention. Botulism Antitoxin Heptavalent (Equine), Types A-G. Available at: www.cdc.gov/laboratory/drugservice/formulary.html#bat. Accessed November 22, 2015.Google Scholar

World Health Organization. Ebola virus disease outbreak 2014–2015. Available at: www.who.int/csr/disease/ebola/en/. Accessed November 22, 2015.Google Scholar

Leroy, EM, Epelboin, A, Mondonge, V, et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis. 2009;9 (6):723–728.Google Scholar

Bausch, DG, Towner, JS, Dowell, SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196 (Suppl 2):S142–S147.Google Scholar

Dowell, SF, Mukunu, R, Ksiazek, TG, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S87.Google Scholar

Centers for Disease Control and Prevention. Infection prevention and control recommendations for hospitalized patients with known or suspected Ebola hemorrhagic fever in U.S. hospitals. Available at: www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html. Accessed on November 21, 2015.Google Scholar

Centers for Disease Control and Prevention. Ebola virus disease information for clinicians in U.S. healthcare settings. Available at: www.cdc.gov/vhf/ebola/hcp/clinician-information-us-healthcare-settings.html. Accessed November 17, 2015.Google Scholar

Fowler, RA, Fletcher, T, Fischer, WA 2nd, et al. Caring for critically ill patients with Ebola virus disease: perspectives from West Africa. Am J Respir Crit Care Med. 2014;190(7):733.Google Scholar

Centers for Disease Control and Prevention. Severe Acute Respiratory Syndrome (SARS). Available at: www.cdc.gov/sars/index.html. Accessed November 22, 2015.Google Scholar

FIneburg, HV. Pandemic preparedness and response: lessons from the H1N1 Influenza of 2009. N Engl J Med. 2014; 370:1335–1342.Google Scholar

Centers for Disease Control and Prevention. Novel influenza A virus infections 2014 Case Definition. Available at: wwwn.cdc.gov/nndss/conditions/novel-influenza-a-virus-infections/case-definition/2014/. Accessed November 22, 2015.Google Scholar

Simonsen, L, Spreeuwenberg, P, Lustig, R, et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013;10:e1001558–e1001558.Google Scholar

Bartlett, JG, Borio, L. The current status of planning for pandemic influenza and implications for health care planning in the United States. Clin Infect Dis. 2008;46:919–925.Google Scholar

Centers for Disease Control and Prevention. FluSurge, version 2.0. Available at: www.cdc.gov/flu/tools/flusurge/. Accessed November 22, 2015Google Scholar

Occupational Safety and Health Administration (OSHA). Guidance on Preparing Workplaces for an Influenza Pandemic. OSHA publication 3327–02 N 2007. Available at: www.osha.gov/Publications/influenza_pandemic.html. Accessed August 26, 2009.Google Scholar

Hick, JL, Hanfling, D, Burstein, JL, et al. Health care facility and community strategies for patient care surge capacity. Ann Emerg Med. 2004;44(3):253–261.Google Scholar

Zaki, AM, van Boheemen, S, Bestebroer, TM, Osterhaus, ADME, Fouchier, RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820Google Scholar

Centers for Disease Control and Prevention. Middle Eastern Respiratory Syndrome. Available at: www.cdc.gov/coronavirus/mers/index.html. Accessed November 22, 2015.Google Scholar